Association of C-reactive protein with cognitive impairment - PubMed (original) (raw)
Association of C-reactive protein with cognitive impairment
James M Noble et al. Arch Neurol. 2010 Jan.
Abstract
Background: High-sensitivity C-reactive protein (hsCRP) is a biomarker of cardiovascular risk that is suggested to be a biomarker for cognitive impairment.
Objective: To explore the association between hsCRP and cognitive impairment.
Design: Cross-sectional analysis of a population-based community aging study.
Setting: Northern Manhattan, New York, New York.
Other participants: One thousand three hundred thirty-one participants from a longitudinal study of aging without dementia and with available hsCRP and neuropsychological testing data at baseline.
Main outcome measures: Four cognitive scores (memory, visuospatial, executive, and language impairment) derived from a neuropsychological battery. Cognitive impairment was defined by scores below 1.5 SDs of demographically corrected means.
Results: Participants in the highest hsCRP tertile had higher adjusted odds of impaired memory (odds ratio [OR], 1.5; 95% confidence interval [CI], 1.0-2.1; P = .03) than participants in the lowest tertile. Subjects in the highest hsCRP tertile also had greater odds of visuospatial impairment (OR, 1.6; 95% CI, 1.0-2.3; P = .03). Higher hsCRP was not associated with executive or language impairment. Persons with at least 1 APOE epsilon4 allele and hsCRP in the highest tertile had the greatest odds of impaired memory (OR, 2.7; 95% CI, 1.6-4.4).
Conclusions: High hsCRP may be a marker of memory and visuospatial impairment in the elderly. The role of APOE epsilon4 requires further exploration.
Similar articles
- Association of prior stroke with cognitive function and cognitive impairment: a population-based study.
Knopman DS, Roberts RO, Geda YE, Boeve BF, Pankratz VS, Cha RH, Tangalos EG, Ivnik RJ, Petersen RC. Knopman DS, et al. Arch Neurol. 2009 May;66(5):614-9. doi: 10.1001/archneurol.2009.30. Arch Neurol. 2009. PMID: 19433661 Free PMC article. - APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA. Ballard CG, et al. Neurology. 2004 Oct 26;63(8):1399-402. doi: 10.1212/01.wnl.0000141851.93193.17. Neurology. 2004. PMID: 15505155 - Elevated levels of high-sensitivity C-reactive protein are associated with mild cognitive impairment and its subtypes: results of a population-based case-control study.
Dlugaj M, Gerwig M, Wege N, Siegrist J, Mann K, Bröcker-Preuss M, Dragano N, Moebus S, Jöckel KH, Bokhof B, Möhlenkamp S, Erbel R, Weimar C. Dlugaj M, et al. J Alzheimers Dis. 2012;28(3):503-14. doi: 10.3233/JAD-2011-111352. J Alzheimers Dis. 2012. PMID: 22008268 - APOE ε4 allele is associated with worse performance in memory dimensions of the mini-mental state examination: the Bambuí Cohort Study of Aging.
Quintino-Santos S, Diniz BS, Firmo JO, Moriguchi EH, Lima-Costa MF, Castro-Costa E. Quintino-Santos S, et al. Int J Geriatr Psychiatry. 2015 Jun;30(6):573-9. doi: 10.1002/gps.4186. Epub 2014 Aug 15. Int J Geriatr Psychiatry. 2015. PMID: 25132317
Cited by
- Causal relationship between Alzheimer's disease and unstable angina: a bidirectional Mendelian randomization analysis.
Chen YH, Ren CY, Yu C. Chen YH, et al. Front Psychiatry. 2024 Jul 9;15:1435394. doi: 10.3389/fpsyt.2024.1435394. eCollection 2024. Front Psychiatry. 2024. PMID: 39045549 Free PMC article. - ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline.
Rao RV, Kumar S, Gregory J, Coward C, Okada S, Lipa W, Kelly L, Bredesen DE. Rao RV, et al. Biomedicines. 2021 Sep 29;9(10):1348. doi: 10.3390/biomedicines9101348. Biomedicines. 2021. PMID: 34680464 Free PMC article. - Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife.
Singh-Manoux A, Dugravot A, Brunner E, Kumari M, Shipley M, Elbaz A, Kivimaki M. Singh-Manoux A, et al. Neurology. 2014 Aug 5;83(6):486-93. doi: 10.1212/WNL.0000000000000665. Epub 2014 Jul 2. Neurology. 2014. PMID: 24991031 Free PMC article. - Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife.
Cohen-Manheim I, Doniger GM, Sinnreich R, Simon ES, Pinchas-Mizrachi R, Otvos JD, Kark JD. Cohen-Manheim I, et al. PLoS One. 2015 Sep 25;10(9):e0138036. doi: 10.1371/journal.pone.0138036. eCollection 2015. PLoS One. 2015. PMID: 26406330 Free PMC article. Clinical Trial. - Dietary Factors and Cognitive Decline.
Smith PJ, Blumenthal JA. Smith PJ, et al. J Prev Alzheimers Dis. 2016 Mar;3(1):53-64. doi: 10.14283/jpad.2015.71. J Prev Alzheimers Dis. 2016. PMID: 26900574 Free PMC article.
References
- Craft S. Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging. 2005 Dec;26(Suppl 1):65–69. - PubMed
- Singer G, Granger DN. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Microcirculation. 2007 Jun-Jul;14(4–5):375–387. - PubMed
- Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007 May;131(5):1557–1566. - PubMed
- Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002 Nov 14;347(20):1557–1565. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 AG007232-20/AG/NIA NIH HHS/United States
- P01AG07232/AG/NIA NIH HHS/United States
- P01 AG007232/AG/NIA NIH HHS/United States
- R01 AG037212/AG/NIA NIH HHS/United States
- R01 AG037212-01/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous